Cargando…

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022

Detalles Bibliográficos
Autores principales:	Twentyman, Evelyn, Wallace, Megan, Roper, Lauren E., Anderson, Tara C., Rubis, Amy B., Fleming-Dutra, Katherine E., Hall, Elisha, Hsu, Joy, Rosenblum, Hannah G., Godfrey, Monica, Archer, W. Roodly, Moulia, Danielle L., Daniel, Laura, Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew, Meyer, Sarah, Oliver, Sara E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368733/ https://www.ncbi.nlm.nih.gov/pubmed/35925807 http://dx.doi.org/10.15585/mmwr.mm7131a2

Ejemplares similares

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
por: Moulia, Danielle L., et al.
Publicado: (2023)

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
por: Mbaeyi, Sarah, et al.
Publicado: (2021)

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
por: Regan, Joanna J., et al.
Publicado: (2023)

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
por: Oliver, Sara E., et al.
Publicado: (2022)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
por: Woodworth, Kate R., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
por: Dooling, Kathleen, et al.
Publicado: (2020)

The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
por: Dooling, Kathleen, et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
por: Wallace, Megan, et al.
Publicado: (2021)

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
por: Dooling, Kathleen, et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
por: Oliver, Sara E., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2020)

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
por: Rosenblum, Hannah G., et al.
Publicado: (2021)

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Melgar, Michael, et al.
Publicado: (2023)

The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022
por: Wallace, Megan, et al.
Publicado: (2022)

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Fleming-Dutra, Katherine E., et al.
Publicado: (2023)

Interim report on Advisory Mechanisms and Organization
por: Ekelöf, T., et al.
Publicado: (2012)

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
por: Bhiman, Jinal N., et al.
Publicado: (2023)

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
por: Gargano, Julia W., et al.
Publicado: (2021)

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
por: MacNeil, Jessica R., et al.
Publicado: (2021)

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Jones, Jefferson M., et al.
Publicado: (2023)

The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
por: McClung, Nancy, et al.
Publicado: (2020)

The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020
por: McClung, Nancy, et al.
Publicado: (2021)

Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013
por: Keitel, Wendy, et al.
Publicado: (2013)

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023
por: Romanson, Brittney, et al.
Publicado: (2023)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2023)

Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review
por: Dadras, Omid, et al.
Publicado: (2022)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2021)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2022)

Advisory Committee of CERN Users (ACCU): Minutes of the 8th Meeting held on 11th July 1990
por: Pattison, Bryan
Publicado: (1990)

Advisory Committee of CERN Users (ACCU): Minutes of the 26th Meeting, held on 4th July 1986
por: Blair, W
Publicado: (1986)

Advisory Committee of CERN Users (ACCU): Minutes of the 14th Meeting, held on July 1st, 1982
por: Blair, W
Publicado: (1982)

Advisory Committee of CERN Users (ACCU): Minutes of the 20th Meeting, held on 2nd July 1984
por: Blair, W
Publicado: (1984)

The Laboratory Advisory Committee
Publicado: (1968)

A Case Report for Acute Myopericarditis After NVX-CoV2373 (Novavax(®)) COVID-19 Vaccination
por: Kim, Hyung Yoon, et al.
Publicado: (2022)

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on vaccine safety on AstraZeneca COVID-19 vaccine
Publicado: (2021)

Summary of the National Advisory Committee on Immunization (NACI) Rapid Response—Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada
por: Killikelly, April, et al.
Publicado: (2022)

Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
por: Collins, Jennifer P., et al.
Publicado: (2022)

Leicester Health Advisory Committee
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_i2pmq4ns0l0mbea99fhnhevng2